For research use only. Not for therapeutic Use.
NVP-DKY709(Cat No.:I043862)is a selective small molecule inhibitor that targets the protein kinase CLK1 (CDC-like kinase 1), involved in RNA splicing and cell cycle regulation. By inhibiting CLK1, NVP-DKY709 disrupts essential processes in cell proliferation and survival, making it a promising candidate for cancer research. It has shown potential in suppressing tumor growth, particularly in cancers that are highly dependent on RNA splicing mechanisms. NVP-DKY709 is used in preclinical studies to explore the role of CLK1 in cancer and to evaluate its therapeutic potential in targeting RNA splicing pathways for cancer treatment.
CAS Number | 2291360-73-9 |
Synonyms | 3-[6-(1-benzylpiperidin-4-yl)-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione |
Molecular Formula | C25H27N3O3 |
Purity | ≥95% |
IUPAC Name | 3-[6-(1-benzylpiperidin-4-yl)-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione |
InChI | InChI=1S/C25H27N3O3/c29-23-9-8-22(24(30)26-23)28-16-20-14-19(6-7-21(20)25(28)31)18-10-12-27(13-11-18)15-17-4-2-1-3-5-17/h1-7,14,18,22H,8-13,15-16H2,(H,26,29,30) |
InChIKey | OMISHRJQMYQPMG-UHFFFAOYSA-N |
SMILES | C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC(=C3)C4CCN(CC4)CC5=CC=CC=C5 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |